目前位置: 財報狗 / 生物製藥 / 生物製藥概念股負債和股東權益排名

生物製藥概念股負債和股東權益排名

生物製藥概念股最新負債和股東權益。點擊股票可查詢歷史數據趨勢。

查看更多標籤
股號 / 名稱 總負債 淨值
AZN AstraZeneca PLC 2,071,992,700,054.2 1,336,120,638,498.8
REGN 雷傑納榮製藥 275,368,088,635.64 961,603,265,194.88
BNTX Biontech SE 119,867,909,257.5 697,117,215,292.68
GILD 吉利德科學 1,302,149,248,754.2 630,485,406,966.8
BIIB Biogen Inc 371,270,927,090.14 547,604,388,592.8
VRTX 福泰製藥 200,604,823,760.88 537,566,940,359.68
BMY 施貴寶 2,498,485,972,074.4 535,123,096,893.0
MRNA 莫德納 106,172,877,687.8 357,109,083,515.8
BIO.B Bio Rad Laboratories Inc 91,555,679,901.84 215,205,641,898.94
AMGN 美國安進 2,816,054,585,559.6 192,526,381,416.6
BMRN BioMarin Pharmaceutical Inc 43,600,984,745.01 185,351,768,043.44
ROIV Roivant Sciences Ltd 19,749,694,936.83 170,003,448,293.82
GMAB Genmab A/S 41,351,698,736.09 166,500,251,099.21
QGEN Qiagen NV 69,524,496,568.31 116,863,513,519.88
INCY 英賽德 65,410,289,368.09 112,941,865,460.36
PCVX Vaxcyte Inc 4,655,489,044.73 111,959,283,142.14
ABBV 艾伯維 4,318,854,521,088.8 108,924,658,535.0
EXAS Exact Sciences Corp 115,904,354,098.15 105,174,079,518.15
GLPG Galapagos NV 47,763,060,132.27 104,399,635,197.38
ILMN Illumina Inc 128,744,032,494.0 77,737,808,933.4
EXEL Exelixis Inc 23,045,738,724.45 73,518,509,912.25
TECH Bio-Techne Corp 19,391,275,481.49 68,089,934,245.93
RGEN Repligen Corp 26,664,690,890.78 66,065,213,209.72
CRSP CRISPR Therapeutics AG 10,153,874,770.39 63,293,580,229.26
RNA Avidity Biosciences Inc 4,500,832,409.26 49,249,670,119.8
ALKS Alkermes Plc 19,347,312,506.52 47,991,614,883.2
DNLI Denali Therapeutics Inc 4,439,474,248.22 43,192,967,715.82
VIR Vir Biotechnology Inc 8,439,744,617.66 40,645,342,800.05
SRPT Sarepta Therapeutics Inc 77,929,876,684.68 40,001,426,081.8
ITCI Intra-Cellular Therapies Inc 5,884,191,952.3 37,503,693,573.53
NUVL Nuvalent Inc 2,218,852,623.13 36,727,298,263.07
LEGN Legend Biotech Corp 20,301,525,274.58 36,562,879,357.45
ABCL Abcellera Biologics Inc 10,310,464,204.32 35,317,600,246.21
IDYA IDEAYA Biosciences Inc 2,127,519,706.44 34,696,909,868.68
CERT Certara Inc 16,046,289,305.94 34,508,805,992.2
NTLA Intellia Therapeutics Inc 6,903,562,959.71 31,534,589,526.52
KRYS Krystal Biotech Inc 3,585,766,999.68 31,002,742,359.2
NEO Neogenomics Inc 24,100,981,160.76 29,559,990,212.88
KYMR Kymera Therapeutics Inc 4,648,937,185.57 29,251,757,998.69
VKTX Viking Therapeutics Inc 918,668,932.12 28,837,287,388.23
LGND Ligand Pharmaceuticals Inc 3,724,338,820.91 27,556,398,922.45
BCYC Bicycle Therapeutics PLC 5,428,673,944.2 27,224,023,107.27
CVAC CureVac NV 4,722,686,942.37 26,430,058,873.45
DNA Ginkgo Bioworks Holdings Inc 22,372,633,473.65 26,140,050,768.54
XENE Xenon Pharmaceuticals Inc 1,247,932,614.21 26,135,595,504.31
BEAM Beam Therapeutics Inc 12,450,170,368.79 25,922,987,674.57
CLDX Celldex Therapeutics Inc 1,221,069,991.65 25,745,694,365.7
IOVA Iovance Biotherapeutics Inc 7,130,388,323.83 25,337,841,132.99
AKRO Akero Therapeutics Inc 2,595,256,931.87 24,187,007,071.53
MYGN Myriad Genetics Inc 11,452,649,811.68 23,969,976,736.86
VRDN Viridian Therapeutics Inc 2,109,829,686.7 23,177,070,741.32
MRUS Merus NV 4,632,655,815.56 23,038,335,123.6
DVAX Dynavax Technologies Corp 12,466,975,887.54 22,323,068,659.11
ZLAB Zai Lab Ltd 10,406,874,811.86 21,872,366,267.49
JANX Janux Therapeutics Inc 1,274,827,996.06 21,493,505,011.56
ITOS Iteos Therapeutics Inc 2,993,708,246.68 20,693,785,082.49
CGEM Cullinan Therapeutics Inc 831,824,038.95 20,568,316,979.58
HRMY Harmony Biosciences Holdings Inc 10,854,170,236.71 19,550,878,770.62
ACAD ACADIA Pharmaceuticals Inc 13,093,497,419.71 18,908,010,349.84
RCUS Arcus Biosciences Inc 22,505,636,214.6 18,509,002,127.0
ARVN Arvinas Inc 17,352,598,985.26 18,400,896,450.86
DAWN Day One Biopharmaceuticals Inc 1,485,437,508.76 18,196,576,722.96
VNDA Vanda Pharmaceuticals Inc 3,854,393,225.24 17,642,387,715.91
PRTA Prothena Corporation PLC 1,994,779,039.85 17,505,322,822.28
KROS Keros Therapeutics Inc 1,521,210,659.77 17,455,299,377.59
SWTX SpringWorks Therapeutics Inc 2,499,435,991.65 17,446,978,516.46
PTGX Protagonist Therapeutics Inc 2,356,769,258.44 17,425,160,825.46
AMRN Amarin Corporation PLC 7,182,148,011.19 17,407,470,805.73
NRIX Nurix Therapeutics Inc 4,663,285,757.13 17,263,919,571.53
EBS Emergent BioSolutions Inc 31,756,861,348.52 16,654,825,984.72
NUVB Nuvation Bio Inc 2,255,968,905.27 16,468,556,628.8
EWTX Edgewise Therapeutics Inc 733,972,022.4 16,015,266,252.82
INSM Insmed Inc 51,417,582,037.96 15,836,334,979.16
ACLX Arcellx Inc 9,234,550,652.36 15,823,329,538.72
REPL Replimune Group Inc 3,972,195,652.93 15,802,232,552.23
AUTL Autolus Therapeutics PLC 11,482,952,160.29 15,625,037,521.25
ALLO Allogene Therapeutics Inc 4,107,098,433.04 15,192,057,908.66
AVIR Atea Pharmaceuticals Inc 1,062,580,518.57 15,020,825,069.51
TWST Twist Bioscience Corp 5,000,346,151.62 14,936,306,086.35
ERAS Erasca Inc 2,583,201,511.01 14,743,059,000.42
CSTL Castle Biosciences Inc 2,408,135,834.26 14,448,651,209.07
KNSA Kiniksa Pharmaceuticals International PLC 3,875,162,618.77 14,316,008,820.37
NKTX Nkarta Inc 3,313,963,122.42 14,115,096,059.23
ANIP ANI Pharmaceuticals Inc 28,060,924,837.07 14,112,639,112.05
IMTX Immatics NV 7,101,080,417.38 13,950,951,366.61
KURA Kura Oncology Inc 1,803,923,382.52 13,882,439,540.46
TRDA Entrada Therapeutics Inc 4,328,911,624.9 13,839,066,232.82
CTKB Cytek Biosciences Inc 3,464,721,401.7 12,627,496,436.96
PRAX Praxis Precision Medicines Inc 1,100,384,745.92 12,535,868,686.6
ETNB 89Bio Inc 2,627,131,726.68 12,386,355,260.57
ZYME Zymeworks Inc 3,936,815,613.47 12,021,940,854.09
SNDX Syndax Pharmaceuticals Inc 1,945,214,225.31 12,004,054,278.59
TERN Terns Pharmaceuticals Inc 450,866,188.1 11,939,780,540.23
HALO Halozyme Therapeutics Inc 55,679,533,662.24 11,918,519,757.25
FATE Fate Therapeutics Inc 4,345,324,032.1 11,869,544,610.03
TYRA Tyra Biosciences Inc 599,626,150.32 11,868,299,756.79
ZNTL Zentalis Pharmaceuticals Inc 3,155,702,964.41 11,607,634,040.11
IMVT Immunovant Inc 2,237,951,292.58 11,551,484,607.11
PLRX Pliant Therapeutics Inc 3,270,786,370.56 11,328,885,192.15
MRVI Maravai LifeSciences Holdings Inc 30,566,879,928.58 11,306,543,352.41

最新要聞